Immunokine Limited is a private limited company situated at Moorcourt House, Upper Pendock, Malvern WR13 6JW. Incorporated on 2020-06-15, this 3-year-old company is run by 1 director.
Director Frank N., appointed on 15 June 2020.
The company is officially classified as "research and experimental development on biotechnology" (SIC: 72110).
The latest confirmation statement was sent on 2023-05-31 and the deadline for the following filing is 2024-06-14. Likewise, the accounts were filed on 30 June 2022 and the next filing is due on 31 March 2024.
Office Address | Moorcourt House |
Office Address2 | Upper Pendock |
Town | Malvern |
Post code | WR13 6JW |
Country of origin | United Kingdom |
Registration Number | 12673199 |
Date of Incorporation | Mon, 15th Jun 2020 |
Industry | Research and experimental development on biotechnology |
End of financial Year | 30th June |
Company age | 4 years old |
Account next due date | Sun, 31st Mar 2024 (58 days after) |
Account last made up date | Thu, 30th Jun 2022 |
Next confirmation statement due date | Fri, 14th Jun 2024 (2024-06-14) |
Last confirmation statement dated | Wed, 31st May 2023 |
The list of PSCs who own or have control over the company includes 1 name. As we established, there is Frank N. The abovementioned PSC has 75,01-100% voting rights and has 75,01-100% shares.
Frank N.
Notified on | 15 June 2020 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Profit & Loss | |||
---|---|---|---|
Accounts Information Date | 2021-06-30 | 2022-06-30 | 2023-06-30 |
Balance Sheet | |||
Cash Bank On Hand | 100 | 100 | |
Net Assets Liabilities | 1 | 100 | 100 |
Other | |||
Called Up Share Capital Not Paid Not Expressed As Current Asset | 100 | 100 | |
Number Shares Allotted | 1 | 100 | 100 |
Par Value Share | 1 | 1 | 1 |
Type | Category | Free download | |
---|---|---|---|
AA |
Dormant company accounts reported for the period up to 2023/06/30 filed on: 15th, March 2024 |
accounts | Free Download (2 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy